Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy
Top Cited Papers
- 1 March 2003
- journal article
- review article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 91 (6), 2-8
- https://doi.org/10.1016/s0002-9149(02)03373-8
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Improving Outcomes in Heart FailureCirculation, 2002
- New Concepts in Diastolic Dysfunction and Diastolic Heart Failure: Part ICirculation, 2002
- Medical Management of Advanced Heart FailureJAMA, 2002
- Rhythm or rate control in atrial fibrillation—Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trialThe Lancet, 2000
- Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trialsJournal of the American College of Cardiology, 1998
- Impact of Atrial Fibrillation on the Risk of DeathCirculation, 1998
- Randomised trial of low-dose amiodarone in severe congestive heart failureThe Lancet, 1994
- Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study.Circulation, 1994
- The epidemiology of heart failure: The Framingham StudyJournal of the American College of Cardiology, 1993
- Effect of Enalapril on Mortality and the Development of Heart Failure in Asymptomatic Patients with Reduced Left Ventricular Ejection FractionsThe New England Journal of Medicine, 1992